Citizens Community Bancorp (CZWI) is a federally chartered savings institution with $1.82B in total assets at March 31, 2026, up from $1.78B at December 31, 2025. Under a liquidation lens, the recovery posture to equity is constrained by the standard community bank structural asymmetry: the dominant asset class is loans held at amortized cost, subject to meaningful credit haircuts, while the liability stack — primarily deposits and subordinated debt — stands at face value with no discount. Reported stockholders' equity was $190.9M at March 31, 2026 ($187.9M at December 31, 2025). MFFAIS CLV/LLV/OLV is reported at $96.6M, reflecting haircuts applied to the loan book and intangibles. The gap between book equity (~$191M) and liquidation value (~$97M) is driven principally by: (1) goodwill of $31.5M carried at book but assigned zero recovery; (2) intangible assets of $0.3M similarly zeroed; (3) the HTM securities portfolio ($79.0M amortized cost vs. $63.0M fair value — an embedded $16M loss not reflected in book equity); (4) the AFS portfolio ($148.1M amortized cost, $130.9M fair value — $17.2M gross unrealized loss already partially captured in AOCI of -$12.2M); and (5) meaningful loan credit risk with nonperforming assets rising to $18.2M (1.00% of assets) from $16.7M at year-end, including $8.97M in multi-family nonaccrual that has been flat for two consecutive quarters, suggesting workout is slow. The ACL-to-loans ratio is 1.69% ($23.0M ACL against $1.36B gross loans), which provides a partial buffer but does not fully offset liquidation-scenario haircuts on the $1.36B loan book. Criticized loans reached $48.4M at March 31, 2026, vs. $45.9M at December 31, 2025 — a 5.5% QoQ increase driven by both special mention and substandard migration. On the liability side, deposits of $1.57B are at face value in liquidation; the $35.0M subordinated note (4.75%, maturing 2032) and $17.0M senior notes (maturing 2039-2040) are similarly face-value obligations. FHLB advances remain at zero. Off-balance sheet unused loan commitments jumped to $332M at March 31, 2026, from $199M at December 31, 2025 — a significant increase that would not extinguish on windup and could require ACL funding if drawn. The MSR asset ($4.8M fair value) would also attract a near-zero recovery haircut in a wind-down scenario. Filing discusses criticized loan composition in MD&A but does not separately XBRL-tag special mention and substandard balances.
▼ Community Notes